Current Issues in Molecular Biology (Sep 2022)

Synthesis and In Silico Study of Some New <i>bis</i>-[1,3,4]thiadiazolimines and <i>bis</i>-Thiazolimines as Potential Inhibitors for SARS-CoV-2 Main Protease

  • Sobhi M. Gomha,
  • Sayed M. Riyadh,
  • Magda H. Abdellattif,
  • Tariq Z. Abolibda,
  • Hassan M. Abdel-aziz,
  • AbdElAziz. A. Nayl,
  • Alaa M. Elgohary,
  • Abdo A. Elfiky

DOI
https://doi.org/10.3390/cimb44100311
Journal volume & issue
Vol. 44, no. 10
pp. 4540 – 4556

Abstract

Read online

A novel series of bis-[1,3,4]thiadiazolimines, and bis-thiazolimines, with alkyl linker, were synthesized through general routes from cyclization of 1,1′-(hexane-1,6-diyl)bis(3-phenylthiourea) and hydrazonoyl halides or α-haloketones, respectively. Docking studies were applied to test the binding affinity of the synthesized products against the Mpro of SARS-CoV-2. The best compound, 5h, has average binding energy (−7.50 ± 0.58 kcal/mol) better than that of the positive controls O6K and N3 (−7.36 ± 0.34 and −6.36 ± 0.31 kcal/mol). Additionally, the docking poses (H-bonds and hydrophobic contacts) of the tested compounds against the Mpro using the PLIP web server were analyzed.

Keywords